DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/z2g564/abortion_global)
has announced the addition of the “Abortion
Global Clinical Trials Review, H2, 2015” report to their
Our clinical trial report, “Abortion Global Clinical Trials Review, H2,
2015” provides an overview of Abortion clinical trials scenario. This
report provides top line data relating to the clinical trials on
Abortion. The report includes an overview of trial numbers and their
average enrollment in top countries conducted across the globe. The
report offers coverage of disease clinical trials by region, country (G7
& E7), phase, trial status, end points status and sponsor type.
Key Topics Covered:
- The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
End point status
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
Benefits of this Report:
Assists in formulating key business strategies with regards to
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing
a comparative scenario of completed and uncompleted (terminated,
suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global,
regional and country level
- Gynuity Health Projects
- Planned Parenthood Federation of America, Inc.
- Pfizer Inc.
Nora Therapeutics, Inc.
- Merck & Co., Inc.
- Ibis Reproductive Health
- Biogen, Inc.
Christiana Care Health System
- Chengdu First Pharmaceutical Co., Ltd.
- Abbott Laboratories
For more information visit http://www.researchandmarkets.com/research/z2g564/abortion_global
Research and Markets
Laura Wood, Senior Manager
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716